MAPT and tauopathy: These findings highlight how templated amplification of protein misfolding and strain-specific differences in clinicopathologic phenotype define tau as a prion-like amyloid protein, and have given rise to a deeper understanding of the mechanisms underpinning disease progression in tauopathies.